Filing Details
- Accession Number:
- 0001493152-25-002850
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-17 19:00:06
- Reporting Period:
- 2025-01-15
- Accepted Time:
- 2025-01-17 19:00:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1795091 | Os Therapies Inc | OSTX | Pharmaceutical Preparations (2834) | 825118368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2048828 | Shalom Auerbach | 15 Atlantic Avenue Suite M2 Lynbrook NY 11563 | No | No | Yes | No | |
2048829 | Einodmil Llc | 396 Oakland Avenue Cedarhurst NY 11516 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Disposition | 2025-01-15 | 16,720 | $6.74 | 2,531,211 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, Par Value $0.001 Per Share | 23,371 | Direct |
Footnotes
- The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares of Comm Stock were sold in multiple transactions at prices ranging from $6.618 to $6.80 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.